Rehabilitation of vision after brain injury
Rehabilitation of Visual Function After Brain Injury - Effect of Neuro Vision Technology (NVT)
NA · University Hospital, Gentofte, Copenhagen · NCT03160131
This study is testing a training program to help people who have had brain injuries, like strokes, improve their vision and quality of life.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 56 (estimated) |
| Ages | 14 Years and up |
| Sex | All |
| Sponsor | University Hospital, Gentofte, Copenhagen (other) |
| Locations | 1 site (Copenhagen, Hellerup) |
| Trial ID | NCT03160131 on ClinicalTrials.gov |
What this trial studies
This study focuses on individuals who have suffered brain injuries, particularly from strokes, and are experiencing significant vision impairments. It utilizes a supervised training program called Neuro Vision Technology (NVT) to help restore visual function and improve quality of life. Participants must be between 14 and 9 months post-injury, with specific visual acuity requirements. The study aims to address the critical need for visual rehabilitation in this population to enhance their daily living activities and reduce the risk of falls.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 14 and older who have experienced a brain injury and have significant vision impairment.
Not a fit: Patients with cognitive dysfunction, severe neglect, or vision impairments not caused by brain damage may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the visual function and overall quality of life for patients with brain injuries.
How similar studies have performed: While similar approaches have been explored, this specific application of Neuro Vision Technology for visual rehabilitation post-brain injury is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * 14 years or older with brain injury. * Persons who experience significant vision impairment. * Eye sight 6/18 or better. * The time from symptoms onset to study inclusion is between 6 weeks and 9 months. Exclusion criteria: * Cognitive dysfunction. * Persons with anosognosia or severe neglect. * Inability to move independently at least 35 meters with or without assistance, including wheelchairs. * Inability to understand Danish or with communication disorders that prevent participation in tests. * Terminal disorder, other progressive disorder. * Significant abuse of alcohol or euphoric or narcotic drugs. * Serious disorders such as mental illness, especially severe depression. * New brain injury or other significant disorders emerging after study inclusion. * Impaired vision not due to brain damage, where the disorder is not considered to be permanent or where the field of vision does not cause significant disability.
Where this trial is running
Copenhagen, Hellerup
- The Institute for the Blind and Partially Sighted (IBOS) — Copenhagen, Hellerup, Denmark (RECRUITING)
Study contacts
- Study coordinator: Nanna F Mikkelsen, OT
- Email: F52E@sof.kk.dk
- Phone: +45 39 45 23 85
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Stroke, Ischemic, Brain Injuries, Stroke Hemorrhagic, Traumatic Brain Injury, Stroke, Visual impairment, Hemianopia, Neuro Vision Technology